1. Home
  2. IMCR

IMCR

Immunocore Holdings plc

Logo Immunocore Holdings plc

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-23-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.

Founded: 2008 Country:
N/A
Employees: N/A City: OXFORDSHIRE
Market Cap: 2.7B IPO Year: 2021
Target Price: $82.50 AVG Volume (30 days): 504.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.40 EPS Growth: N/A
52 Week Low/High: $42.21 - $76.98 Next Earning Date: 01-01-0001
Revenue: $249,428,000 Revenue Growth: 43.05%
Revenue Growth (this year): -3.32% Revenue Growth (next year): 4.77%

Share on Social Networks: